Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Mitsubishi Tanabe Ph (MTZXF)

Mitsubishi Tanabe Ph (MTZXF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mitsubishi Tanabe Ph

Description:

Mitsubishi Tanabe Pharma Corp was incorporated on December 15, 1933. The Company along with its subsidiaries is engaged in the development, manufacturing, procurement, and sale of pharmaceuticals centered on ethical drugs and over-the-counter, or OTC drugs in Japan and overseas. Its products include Remicade, for the treatment of RA, Crohn's Disease, psoriasis, ulcerative colitis; Ceredist, for the treatment of spinocerebellar degeneration; Talion, for the treatment of allergic disorders; Maintate, for the treatment of hypertension, angina pectoris, extrasystole, chronic heart failure, and atrial fibrillation; Radicut, for cerebral neuroprotectant; Kremezin, Simponi, for the treatment of chronic kidney disease; Telavic, for the treatment of RA; Lexapro, for the treatment of depression; Imusera, for the treatment of multiple sclerosis;and Tenelia, for the treatment of f type 2 diabetes mellitus. In addition, the Company has vaccines, generic drugs and OTC drugs. The Company's customers include Suzuken Co. Ltd., Toho Pharmaceutical Co., Ltd., Alfresa Corporation, and Mediceo Corporation, among others.

Key Statistics

Overview:

Annual Sales, $ 0 K
Annual Net Income, $ 0 K

Growth:

1-Year Return 25.12%
3-Year Return 0.00%
5-Year Return 0.00%

Per-Share Information:

Latest Earnings Date N/A
Next Ex-Dividends Date 03/27/15
Dividend Payable Date 12/01/14
Dividend Payout Ratio 0.00%

MTZXF Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % N/A
Return-on-Assets % N/A
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Cash Flow 17.81
Price/Book 1.31
Book Value/Share N/A
Interest Coverage N/A
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar